The patient was first diagnosed with bilateral DVTs on [**3-19**], and was started on lovenox.
The patient was evaluated by his oncologist, who increased his fentaynl patch for radiating abdominal pain, and referred him for a CT torso with contrast to evaluate for progression of disease.
CT showed multiple segmental pulmonary emboli, and thrombus surrounding the tip of his porto-cath extending into his low SVC.
He was admitted to the ICU for close monitoring given ongoing tachycardia.
On admission to the [**Hospital Unit Name 153**], VS 116 20 160/73 100%.
Past Medical History: - IPMN - adenocarcinoma of the pancreas (see below) - Hypertension - Hyperlipidemia - Elevated PSA since approx [**2179**] with 4 negative Bx - Microscopic hematuria - Colon polyps (benign) (last colonoscopy [**2187**], planned 5-year follow-up) - Glaucoma (mild, low tension) - Nephrolithiasis - h/o tendonitis (R index) - Diverticulosis - Lumbar disc disease - Ventral hernia - h/o positive PPD - s/p fusion of lower spine ([**2179**]) .
ONCOLOGIC HISTORY: - [**10-17**] diagnosed with IPMN - [**1-/2192**]: admitted to [**Hospital1 112**] with intense, crampy abdominal pain.
MRI showed a lesion in the uncinate head of the pancreas.
- [**2192-2-16**]: EUS done at [**Hospital1 18**] showed a 2.5 x 2.5 cm mass in the uncinate process of the pancreas as well as several cysts.
Biopsy of the uncinate mass was suspicious for adenocarcinoma.
- [**2192-4-9**]: Gemcitabine 1000mg/m2 day 1 - [**Date range (1) 101157**]: admitted for jaundice, hyperbilirubinemia, biliary obstruction.
ERCP was done with sphincterotomy and CBD stent placed - [**2192-4-16**]: Gemcitabine 1000mg/m2 day 8 - [**2192-4-23**]: day 15 Gemcitabine HELD due to dehydration - [**2192-5-1**]: Gemcitabine given  Social History: Originally from [**Location (un) 4708**].
Physical Exam: Physical Exam: Vitals:  BP 154/81  P 101  O2 99%RA General: Pleasant, Alert, oriented, no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL Neck: supple, JVP not elevated, no LAD CV: Regular rate and rhythm, normal S1 + S2, + S4 and loud P2 Lungs: Clear to auscultation bilaterally, no wheezes, rales, ronchi Abdomen: soft, non-distended, bowel sounds present, + hepatomegaly, no tenderness to palpation, no rebound or guarding  GU: no foley Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema; no calf tenderness Neuro: CNII-XII intact, 5/5 strength upper/lower extremities, grossly normal sensation, 2+ reflexes bilaterally, gait deferred.
Pertinent Results: Admission Labs: [**2192-5-9**] 07:00PM BLOOD WBC-8.8 RBC-2.55* Hgb-7.5* Hct-25.3* MCV-99* MCH-29.2 MCHC-29.5* RDW-16.0* Plt Ct-190 [**2192-5-9**] 07:00PM BLOOD Neuts-94.6* Lymphs-4.3* Monos-0.4* Eos-0.5 Baso-0.2 [**2192-5-9**] 07:00PM BLOOD PT-12.9* PTT-27.2 INR(PT)-1.2* [**2192-5-9**] 07:00PM BLOOD Glucose-173* UreaN-15 Creat-0.8 Na-137 K-4.2 Cl-103 HCO3-24 AnGap-14 [**2192-5-10**] 02:57AM BLOOD Calcium-8.0* Phos-4.2 Mg-1.7 .
Imaging: CT chest/abd/pelvis with contrast: 1.
An independent pathology, such as myxoma or other tumor cannot be entirely excluded.
No atrial septal defect or patent foramen ovale is seen by 2D, color Doppler or saline contrast with maneuvers.
Discharge Labs:  [**2192-5-12**] 06:00AM BLOOD WBC-4.8 RBC-3.28* Hgb-9.8* Hct-31.5* MCV-96 MCH-29.8 MCHC-31.1 RDW-15.7* Plt Ct-207 [**2192-5-12**] 06:00AM BLOOD PT-12.8* PTT-28.3 INR(PT)-1.2* [**2192-5-12**] 06:00AM BLOOD Glucose-173* UreaN-13 Creat-0.7 Na-132* K-4.5 Cl-96 HCO3-25 AnGap-16 [**2192-5-11**] 06:00AM BLOOD ALT-43* AST-23 AlkPhos-177* TotBili-1.0 [**2192-5-12**] 06:00AM BLOOD Calcium-9.0 Phos-3.4 Mg-2.1  Brief Hospital Course: 67 year old male with a history of metastatic pancreatic cancer and recent history of DVT ([**3-19**]) on Lovenox admitted with bilateral PEs and SVC clot surrounding porto-cath.
No evidence of right heart strain on physical exam or EKG.
He underwent LENIs that showed partially occlusive thrombus in the mid superficial femoral vein on the left.
His port stopped drawing and TPA did not work to unclot the port.
# Anemia:  Patient admitted with HCT 25, trending down over the past several months.
Follow-up HCT 21, without localizing source of bleed.
Patient was transfused 1 unit PRBCs and hematocrit remained stable.
He was transferred to the floor and Hct remained stable.
1 DROP BOTH EYES [**Hospital1 **] Polyethylene Glycol 17 g PO/NG DAILY:PRN constipation Docusate Sodium 100 mg PO/NG [**Hospital1 **] Fentanyl Patch 100 mcg/hr TP Q72H Senna 1 TAB PO/NG [**Hospital1 **]:PRN constipation Terazosin 2 mg PO HS Latanoprost 0.005% Ophth.
Medication Changes: Stop taking Megestrol Acetate Stop taking Lovenox Start taking Fondaparinux Sodium 7.5mg subcutaneously daily  In addition, your port was clotted during this hospitalization, and you will need a study as an outpatient to evaluate if your port can be used in the future.
Followup Instructions: You will need a flow study as an outpatient of your port.
Department: HEMATOLOGY/ONCOLOGY When: MONDAY [**2192-5-14**] at 12:00 PM With: [**Doctor Last Name 24141**], RN [**Telephone/Fax (1) 22**] Building: [**Hospital6 29**] [**Location (un) 24**] Campus: EAST     Best Parking: [**Hospital Ward Name 23**] Garage  Department: ENDO SUITES When: THURSDAY [**2192-5-17**] at 1:30 PM  Department: DIGESTIVE DISEASE CENTER When: THURSDAY [**2192-5-17**] at 1:30 PM With: [**Name6 (MD) 1948**] [**Last Name (NamePattern4) 1949**], MD [**Telephone/Fax (1) 463**] Building: [**First Name8 (NamePattern2) **] [**Hospital Ward Name 1950**] Building ([**Hospital Ward Name 1826**]/[**Hospital Ward Name 1827**] Complex) [**Location (un) 1951**] Campus: EAST     Best Parking: Main Garage
